which is a generic for Bayer AG’s Omnipen-N. Ampicillin and dulbactam for injection, which is a generic of Pfizer’s Unasyn. Nafcillin for injection, which is a generic of Baxter Healthcare’s ...

Combined, these products generated U.S. sales of approximately $175M for the twelve months ended September 30, 2024, representing a meaningful opportunity in the generic injectables market. "The ...